Predictive value of controlling nutritional status score in prognosis of naive elderly patients with diffuse large B-cell lymphoma
李欣妍,雷豆,冯慧,罗敏娜,贺鹏程,王晓宁,马盼盼,刘海波,刘依,牛凡
DOI: https://doi.org/10.3760/cma.j.cn511693-20200612-00127
2021-01-01
Abstract:Objective:To investigate the predictive value of controlling nutritional status (CONUT)score in prognosis of naive elderly patients with diffuse large B-cell lymphoma (DLBCL).Methods:From January 2013 to December 2018, a total of 129 elderly patients with DLBCL who were first treated in Department of Hematology, First Affiliated Hospital of Xi′an Jiaotong University were selected as research subjects. The median age of patients was 66 years.And there were 75 male patients and 54 females. Retrospectively analyzed the patient′s clinical data, and obtained the CONUT score based on the patient′s serum ablumin value, serum fofal cholesterol (TC) level, and lymphocyte (Lym) count before chemotherapy. And through receiver operating characteristic (ROC) curve, CONUT score of the best cut-off value was obtained, then patients were divided into high and low CONUT score groups according to the best cut-off value of CONUT score. The composition ratio of different clinical features between groups was compared using the Chi-square test. Log-rank test was used to conduct a univariate analysis of OS rate in elderly patients with DLBCL, and then a multivariate Cox proportional hazard model was used for multivariate analysis with the influencing factors in univariate analysis results with statistical significance. This study was in line with World Medical Association Declaration of Helsinki revised in 2013 and informed contents were obtained from the subjects. Results:① According to ROC curve, the best cut-off value of CONUT score for survival outcome of patients was 3.5 scores, sensitivity was 71.4%, specificity was 60.0%, and ROC-area under curve (AUC) was 0.705(95% CI: 0.614-0.795). ② Patients were divided into high CONUT score group (CONUT score ≥3.5 scores, n=78) and low CONUT score group (CONUT score <3.5 scores, n=51). By comparing composition ratio of age, B symptoms, Ann Arbor staging, hemoglobin (Hb) value before chemotherapy, serum lactate dehydrogenase (LDH) level before chemotherapy, and international prognostic index (IPI) score between patients two groups, the differences were statistically significant ( χ2=4.575, 7.382, 15.656, 15.530, 7.696, 17.808; P=0.032, 0.007, <0.001, <0.001, 0.006, <0.001). ③ The results of univariate survival analysis of factors that may affect the OS rate of 129 elderly patients with DLBCL in this study showed that age, B symptoms, Ann Arbor staging, Hb value before chemotherapy, serum LDH level before chemotherapy, and serum β 2-microbe globulin (MG) before chemotherapy, rituximab in chemotherapy regimens, number of chemotherapy courses, IPI risk stratification and CONUT score were the influencing factors of 3-year OS rate in elderly patients with DLBCL ( χ2=6.229, 6.690, 5.037, 8.937, 13.588, 11.174, 4.806, 15.787, 12.491, 13.838, P=0.013, 0.010, 0.025, 0.003, < 0.001, 0.001, 0.028, <0.001, 0.006, <0.001). ④ The results of multivariate Cox proportional hazard models showed that the CONUT score ≥3.5 scores ( HR=2.26, 95% CI: 1.23-4.14, P=0.009), chemotherapy course with 2-5 courses ( HR=2.89, 95% CI: 1.60-5.21, P<0.001) and LDH value≥250 U/L before chemotherapy ( HR=2.44, 95% CI: 1.23-4.59, P=0.006) were independent risks affecting OS rate in elderly patients with DLBCL. Conclusions:CONUT score is an independent prognostic risk factor for naive elderly patients with DLBCL. CONUT score is a simple, objective and convenient means of evaluating malnutrition. Clinicians should pay attention to malnutrition patients and take individualized treatment measures.